These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 55882)

  • 21. [Role of the genital herpes virus in the cancer of the cervix uteri].
    Thiry L; Sprecher-Goldberger S
    Bull Acad R Med Belg; 1974; 129(1 pt 2):109-41. PubMed ID: 4377231
    [No Abstract]   [Full Text] [Related]  

  • 22. Herpes simplex virus type 2 and cervical cancer.
    Aurelian L
    Clin Dermatol; 1984; 2(2):90-9. PubMed ID: 6100718
    [No Abstract]   [Full Text] [Related]  

  • 23. A study on the relationship between human papillomavirus infection and cervical carcinoma development. Immunoperoxidase localization of papillomavirus antigen in cervical tissue.
    Su LL
    Chin Med J (Engl); 1987 Sep; 100(9):750-2. PubMed ID: 2832133
    [No Abstract]   [Full Text] [Related]  

  • 24. [New antigen induced by herpes simplex virus in human tumors].
    Posevaia TA; Kosiakova NP; Barinskiĭ IF; Kosiakov PN; Pavliuchenkova RP
    Vopr Virusol; 1981; (5):597-601. PubMed ID: 6278776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 26. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 28. [Etiological role of the herpes simplex virus in causing cervical cancer].
    Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
    Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer.
    Aurelian L; Strnad BC; Smith MF
    Cancer; 1977 Apr; 39(4 Suppl):1834-49. PubMed ID: 192436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus and carcinoma of the cervix.
    Thiry L
    Eur J Cancer (1965); 1976 Nov; 12(11):851-8. PubMed ID: 186268
    [No Abstract]   [Full Text] [Related]  

  • 31. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 32. Cervical carcinogenesis with herpes simplex virus, type 2.
    Wentz WB; Reagan JW; Heggie AD
    Obstet Gynecol; 1975 Aug; 46(2):117-21. PubMed ID: 168521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes virus infection and uterine cervix carcinoma. General considerations, personal experimental data and suggestions for a specific antiherpes adjuvant therapy.
    Nastac E; Hozoc M; Stoian M
    Virologie; 1982; 33(2):163-8. PubMed ID: 6293167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Herpes simplex virus and cancer].
    Lehtinen M; Lehtinen T; Leinikki P
    Duodecim; 1982; 98(9):664-73. PubMed ID: 6286271
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of herpes simplex-associated antigens and antibodies in patients with cervical carcinoma in Buenos Aires.
    Teyssié AR; Ayerra de Holstein B; Alonio L; Distéfano A; Lucero J; Pasqualini RS; de Torres RA
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):123-7. PubMed ID: 6258793
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 37. Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix.
    Thiry L; Sprecher-Goldberger S; Fassin Y; Gould I; Gompel C; Pestiau J; De Halleux F
    Am J Epidemiol; 1974 Oct; 100(4):251-61. PubMed ID: 4370721
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
    Chiphangwi JD
    IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Herpes simplex virus type 2 and cervix cancer].
    te Velde ER; The TH
    Ned Tijdschr Geneeskd; 1978 Aug; 122(33):1226-30. PubMed ID: 209356
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of human papilloma and other viruses.
    Baird PJ
    Clin Obstet Gynaecol; 1985 Mar; 12(1):19-32. PubMed ID: 2986895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.